Specialty pharmaceutical company Kyowa Kirin aims to be as diverse as it is multinational. Between April 2020 and today, the executive board of Kyowa Kiran North America (KKNA) has grown from being predominantly male to a 50/50 gender split, and the company is by no means stopping there. North America is the company’s fastest-growing region, having expanded […]

Dr. Edith Perez, Chief Medical Officer of Bolt Biotherapeutics, discusses how she approaches drug development in oncology, and what she contributes outside of work to help raise awareness for cancer.

A recent Business Insider review of 182 pharmaceutical companies revealed that more than 90% of their CEOs were male. A June 2021 BIO report found a bit more diversity elsewhere in the C-suite, where 3 in 10 executive biopharma positions are filled by women. At specialty pharmaceutical company Kyowa Kirin North America (KKNA), VP of Public Affairs and Head […]